Cargando…
Development and validation of the CAIL prognostic score in non‐small cell lung cancer patients with malignant pleural effusion
BACKGROUND: Patients with malignant pleural effusion (MPE) typically have poor prognoses, and predicting survival is challenging. The present study aimed to identify prognostic factors of overall survival (OS) in non‐small cell lung cancer (NSCLC) patients with MPE in the time of immunotherapy and t...
Autores principales: | Li, Tianyuan, Tian, Panwen, Huang, Qin, Zeng, Hao, Wei, Qi, Li, Yalun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632079/ https://www.ncbi.nlm.nih.gov/pubmed/37723659 http://dx.doi.org/10.1111/crj.13700 |
Ejemplares similares
-
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
por: Clive, Amelia O, et al.
Publicado: (2014) -
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion
por: Yang, Min-Fu, et al.
Publicado: (2019) -
The clinical features and prognosis of fungal pleural infection: A case series and literature review
por: Jing, Yawan, et al.
Publicado: (2023) -
Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion
por: Shi, Xin‐Yu, et al.
Publicado: (2019) -
Score for Differentiating Pleural Tuberculosis from Malignant Effusion
por: González, Alejandra, et al.
Publicado: (2019)